Professor Tim Blower timothy.blower@durham.ac.uk
Professor
A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents
Blower, T.R.; Bandak, A.; Lee, A.S.Y.; Austin, C.A.; Nitiss, J.L.; Berger, J.M.
Authors
A. Bandak
A.S.Y. Lee
C.A. Austin
J.L. Nitiss
J.M. Berger
Abstract
Type II topoisomerases catalyze essential DNA transactions and are proven drug targets. Drug discrimination by prokaryotic and eukaryotic topoisomerases is vital to therapeutic utility, but is poorly understood. We developed a next-generation sequencing (NGS) approach to identify drug-resistance mutations in eukaryotic topoisomerases. We show that alterations conferring resistance to poisons of human and yeast topoisomerase II derive from a rich mutational ‘landscape’ of amino acid substitutions broadly distributed throughout the entire enzyme. Both general and discriminatory drug-resistant behaviors are found to arise from different point mutations found at the same amino acid position and to occur far outside known drug-binding sites. Studies of selected resistant enzymes confirm the NGS data and further show that the anti-cancer quinolone vosaroxin acts solely as an intercalating poison, and that the antibacterial ciprofloxacin can poison yeast topoisomerase II. The innate drug-sensitivity of the DNA binding and cleavage region of human and yeast topoisomerases (particularly hTOP2β) is additionally revealed to be significantly regulated by the enzymes’ adenosine triphosphatase regions. Collectively, these studies highlight the utility of using NGS-based methods to rapidly map drug resistance landscapes and reveal that the nucleotide turnover elements of type II topoisomerases impact drug specificity.
Citation
Blower, T., Bandak, A., Lee, A., Austin, C., Nitiss, J., & Berger, J. (2019). A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents. Nucleic Acids Research, 47(15), 8163-8179. https://doi.org/10.1093/nar/gkz579
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 21, 2019 |
Online Publication Date | Jul 9, 2019 |
Publication Date | Sep 5, 2019 |
Deposit Date | Jun 21, 2019 |
Publicly Available Date | Jul 30, 2019 |
Journal | Nucleic Acids Research |
Print ISSN | 0305-1048 |
Electronic ISSN | 1362-4962 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 47 |
Issue | 15 |
Pages | 8163-8179 |
DOI | https://doi.org/10.1093/nar/gkz579 |
Public URL | https://durham-repository.worktribe.com/output/1299083 |
Files
Published Journal Article
(10.9 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Published Journal Article (Advance online version)
(10.9 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
Advance online version © The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
You might also like
Naturally mutagenic sequence diversity in a human type II topoisomerase
(2023)
Journal Article
Conserved domains can be found across distinct phage defence systems
(2023)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search